Editas Medicine (EDIT) Receivables (2016 - 2025)
Historic Receivables for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to $8.1 million.
- Editas Medicine's Receivables rose 635238.1% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 635238.1%. This contributed to the annual value of $16.3 million for FY2024, which is 5967.41% up from last year.
- Latest data reveals that Editas Medicine reported Receivables of $8.1 million as of Q3 2025, which was up 635238.1% from $588000.0 recorded in Q2 2025.
- Editas Medicine's Receivables' 5-year high stood at $16.3 million during Q4 2024, with a 5-year trough of $120000.0 in Q3 2022.
- Moreover, its 5-year median value for Receivables was $588000.0 (2025), whereas its average is $2.6 million.
- As far as peak fluctuations go, Editas Medicine's Receivables plummeted by 9558.53% in 2021, and later skyrocketed by 635238.1% in 2025.
- Over the past 5 years, Editas Medicine's Receivables (Quarter) stood at $267000.0 in 2021, then soared by 1826.97% to $5.1 million in 2022, then surged by 98.0% to $10.2 million in 2023, then soared by 59.67% to $16.3 million in 2024, then crashed by 50.02% to $8.1 million in 2025.
- Its last three reported values are $8.1 million in Q3 2025, $588000.0 for Q2 2025, and $510000.0 during Q1 2025.